USPTO serial 50055833
NEOMUNE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with NEOMUNE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rachelle A. Dubow
Rachelle A. Dubow Morgan, Lewis & Bockius LLPOne Federal StreetBoston, MA 02110United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals for the treatment of oncological disease and disorders, cancer and tumors; pharmaceutical preparations for use in immunotherapy for the treatment of oncological disease and disorders | ACTIVE | — |
| 035 | Medical appointment scheduling services; confirming scheduled appointments for others in the field of cancer treatments; physician referral services; hospital referral services; providing online business directories featuring physicians and hospitals on the internet; processing of online orders of prescriptions in retail and central fill pharmacies; Business management in the field of clinical trials, namely, management of clinical trial information; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of medical treatments and pharmaceuticals | ACTIVE | — |
| 044 | Medical services, namely, resection of tumor and modifying cells for the treatment of cancer and other diseases and medical conditions; immunotherapy treatments; medical diagnostic and treatment services; providing information in the field of oncology and immunotherapy treatments; providing medical information, consultancy and advisory services; providing a web site featuring medical information and information relating to pharmaceuticals; providing medical and health information relating to pharmaceuticals; medical, telehealth, remote care and virtual health care services, namely, providing medical services and consultation over the telephone and via the Internet through the use of personal computers, smartphones, tablets, and mobile wireless devices via video, email, or a global computer network; providing medical services, telehealth services in the nature of telemedicine services, remote health care services, and virtual health care services via a web site and mobile app featuring health and medical information; providing telemedicine and virtual health care services for the diagnosis, consultation, and treatment of oncological or immune system conditions; medical counseling; consulting services in the field of medical care; medical, immunotherapy and pharmaceutical consultation; medical analysis services for diagnostic and treatment purposes provided by medical laboratories | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 28, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 17, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 17, 2026 | NWAP | NEW APPLICATION ENTERED | — |